These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3133685)

  • 1. Panic disorder, vertigo, and the protirelin (TRH) test.
    Hamlin CL
    Psychiatry Res; 1988 Mar; 23(3):349-50. PubMed ID: 3133685
    [No Abstract]   [Full Text] [Related]  

  • 2. TSH and catecholamine response to TRH in panic disorder.
    Castellani S; Quillen MA; Vaughan DA; Hund MA; Ho L; Ziegler MG; Le Vine WR
    Biol Psychiatry; 1988 May; 24(1):87-90. PubMed ID: 3130900
    [No Abstract]   [Full Text] [Related]  

  • 3. TSH response to TRH in depression with and without panic attacks.
    Gillette GM; Garbutt JC; Quade DE
    Am J Psychiatry; 1989 Jun; 146(6):743-8. PubMed ID: 2499197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical growth-hormone responses to thyrotropin-releasing hormone in panic disorder.
    Tancer ME; Stein MB; Uhde TW
    Biol Psychiatry; 1990 Jun; 27(11):1227-30. PubMed ID: 2112960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced TSH and prolactin responses to TRH in patients with panic disorder.
    Roy-Byrne PP; Uhde TW; Rubinow DR; Post RM
    Am J Psychiatry; 1986 Apr; 143(4):503-7. PubMed ID: 3082224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine, cardiovascular, and behavioral effects of intravenous protirelin in patients with panic disorder.
    Stein MB; Uhde TW
    Arch Gen Psychiatry; 1991 Feb; 48(2):148-56. PubMed ID: 1899183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response studies with protirelin.
    Garbutt JC; Mayo JP; Little KY; Gillette GM; Mason GA; Dew B; Prange AJ
    Arch Gen Psychiatry; 1994 Nov; 51(11):875-83. PubMed ID: 7944876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between chronobiological thyrotropin and prolactin responses to protirelin (TRH) and suicidal behavior in depressed patients.
    Duval F; Mokrani MC; Erb A; Gonzalez Opera F; Calleja C; Paris V
    Psychoneuroendocrinology; 2017 Nov; 85():100-109. PubMed ID: 28843902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetics and pharmacodynamics of protirelin (TRH) in man].
    Duntas L; Keck FS; Loos U; Pfeiffer EF
    Dtsch Med Wochenschr; 1988 Sep; 113(35):1354-7. PubMed ID: 3137012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple hormonal responses to protirelin (TRH) in depressed patients.
    Winokur A; Amsterdam JD; Oler J; Mendels J; Snyder PJ; Caroff SN; Brunswick DJ
    Arch Gen Psychiatry; 1983 May; 40(5):525-31. PubMed ID: 6404233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid failure and protirelin (thyrotropin-releasing hormone) test abnormalities in depressed outpatients.
    Sternbach HA; Gold MS; Pottash AC; Extein I
    JAMA; 1983 Mar; 249(12):1618-20. PubMed ID: 6402617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dorsal periaqueductal gray matter-evoked panic-like behaviors are markedly inhibited by a low peripheral dose of thyrotropin releasing hormone.
    Siqueira CC; Rossoni RR; Schenberg LC
    Psychoneuroendocrinology; 2010 Feb; 35(2):262-71. PubMed ID: 19631472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protirelin (thyrotropin-releasing hormone) in thyroid gland: possible involvement in regulation of thyroid status.
    Smyth DG; del Rio-Garcia J; Wallnöfer H; Gogl H; Simma W; Huber A; Embacher R; Fraser H; Kreil G
    Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):289-91. PubMed ID: 10452110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral and endocrine responses of schizophrenic patients to TRH (protirelin).
    Prange AJ; Loosen PT; Wilson IC; Meltzer HY; Fang VS
    Arch Gen Psychiatry; 1979 Sep; 36(10):1086-93. PubMed ID: 112944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protirelin (thyrotropin-releasing hormone) in amyotrophic lateral sclerosis. The role of androgens.
    Miller SC; Warnick JE
    Arch Neurol; 1989 Mar; 46(3):330-5. PubMed ID: 2563937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine effects of ovine corticotropin-releasing hormone in panic disorder patients.
    Rapaport MH; Risch SC; Golshan S; Gillin JC
    Biol Psychiatry; 1989 Aug; 26(4):344-8. PubMed ID: 2548630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine screening of thyroid indices in patients with panic attacks.
    Stein MB; Uhde TW
    J Clin Psychiatry; 1988 May; 49(5):204-5. PubMed ID: 3130374
    [No Abstract]   [Full Text] [Related]  

  • 18. Basic and clinical studies with corticotropin-releasing hormone. Implications for a possible role in panic disorder.
    Gold PW; Pigott TA; Kling MA; Kalogeras K; Chrousos GP
    Psychiatr Clin North Am; 1988 Jun; 11(2):327-34. PubMed ID: 3047702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panic disorder and the vestibular system.
    Jacob RG
    Psychiatr Clin North Am; 1988 Jun; 11(2):361-74. PubMed ID: 3047705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Panic-related responses to pentagastrin, flumazenil, and thyrotropin-releasing hormone in healthy volunteers.
    Zedkova L; Coupland NJ; Man GC; Dinsa G; Sanghera G
    Depress Anxiety; 2003; 17(2):78-87. PubMed ID: 12621596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.